Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Orion Oyj B | Helsinki | Healthcare | Pharmaceuticals | €9.60B | 25.4x | 0.41 | €68.20 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.4% Upside | Upgrade to Pro+ | |
Orion Oyj A | Helsinki | Healthcare | Pharmaceuticals | €9.57B | 25.3x | 0.41 | €68 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Terveystalo | Helsinki | Healthcare | Healthcare Providers & Services | €1.34B | 15x | 0.03 | €10.58 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.5% Upside | Upgrade to Pro+ | |
Revenio Group | Helsinki | Healthcare | Healthcare Equipment & Supplies | €645.12M | 35.8x | -4.95 | €24.25 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.9% Upside | Upgrade to Pro+ | |
Pihlajalinna Oy | Helsinki | Healthcare | Healthcare Providers & Services | €355.19M | 10.7x | 0.03 | €15.85 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.5% Upside | Upgrade to Pro+ | |
Faron Pharmaceuticals Oy | Helsinki | Healthcare | Biotechnology & Medical Research | €261M | -8x | -0.3 | €2.38 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 43.9% Upside | Upgrade to Pro+ | |
Oriola-KD Oyj B | Helsinki | Healthcare | Pharmaceuticals | €221.18M | -7.2x | 0.24 | €1.19 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.7% Upside | Upgrade to Pro+ | |
Detection Technology OY | Helsinki | Healthcare | Healthcare Equipment & Supplies | €146.56M | 16.4x | 1.51 | €10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15% Upside | Upgrade to Pro+ | |
Nightingale Health Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | €141.52M | -9.6x | -1.56 | €2.10 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.1% Upside | Upgrade to Pro+ | |
Solar Foods Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | €138.99M | -13.1x | -1.24 | €5.55 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.6% Downside | Upgrade to Pro+ | |
Nexstim | Helsinki | Healthcare | Healthcare Equipment & Supplies | €104.16M | -328.8x | -4.99 | €13.15 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.9% Downside | Upgrade to Pro+ | |
Nanoform Finland Plc | Helsinki | Healthcare | Biotechnology & Medical Research | €77.83M | -3.3x | -0.68 | €0.83 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Optomed | Helsinki | Healthcare | Healthcare Equipment & Supplies | €76.03M | -13.4x | 1.94 | €3.77 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.3% Upside | Upgrade to Pro+ | |
Modulight Oyj | Helsinki | Healthcare | Healthcare Equipment & Supplies | €53.11M | -9.2x | -0.21 | €1.30 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Herantis Pharma Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | €43.01M | -7.2x | 0.01 | €1.78 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.6% Upside | Upgrade to Pro+ | |
Biohit Oyj B | Helsinki | Healthcare | Pharmaceuticals | €42.36M | 18.7x | 0.51 | €2.79 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.7% Upside | Upgrade to Pro+ | |
Bioretec Oy | Helsinki | Healthcare | Healthcare Equipment & Supplies | €40.94M | €1.30 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |